Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies

被引:160
作者
Higuchi, M
Tashiro, M
Arai, H [1 ]
Okamura, N
Hara, S
Higuchi, S
Itoh, M
Shin, RW
Trojanowski, JQ
Sasaki, H
机构
[1] Tohoku Univ, Sch Med, Dept Geriatr Med, Sendai, Miyagi 980, Japan
[2] Kurihama Natl Hosp, Dept Psychiat, NIA, Kanagawa 239, Japan
[3] Tohoku Univ, Ctr Cyclotron & Radioisotope, Div Nucl Med, Sendai, Miyagi 980, Japan
[4] Tohoku Univ, Sch Med, Dept Neurol Sci, Sendai, Miyagi 980, Japan
[5] Univ Penn, Dept Pathol & Lab Med, Div Anat Pathol, Philadelphia, PA 19104 USA
关键词
dementia with Lewy bodies; Alzheimer's disease; positron emission tomography; spongiform change; gliosis; subcortical white matter;
D O I
10.1006/exnr.2000.7342
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Cerebral glucose metabolism using positron emission tomography (PET) with F-18-fluorodeoxyglucose was examined in 11 patients with probable Alzheimer's disease (AD), 6 patients with probable, and 1 patient with autopsy-confirmed dementia with Lewy bodies (DLB) as well as in 10 age-matched normal control subjects, Among widespread cortical regions showing glucose hypometabolism in the DLB group, the metabolic reduction was most pronounced in the visual association cortex compared to that in the AD group, Using a metabolic ratio of 0.92 in the visual association cortex as a cutoff (mean-2 SD of normal control subjects), DLB could be distinguished from AD with a sensitivity of 86% and a specificity of 91%, In contrast, apolipoprotein E4 allele frequency and cerebrospinal fluid tau levels did not differ significantly between the two groups. In order to further dissect out neuropathological correlates of the dysfunctional occipital lobe, postmortem brains from 19 patients with AD and 17 with DLB as well as 11 brains from normal controls were examined. A distinct and extensive spongiform change with coexisting gliosis was variably noted throughout cerebral white matter with relative sparing of gray matter in DLB, Notably, the white matter spongiform change and gliosis was most prominently and consistently found in the occipital region of DLB, and the severity of the spongiform change in each brain region generally paralleled to the regional difference in reduced glucose metabolism between the living AD and DLB patients. These findings suggest that (1) among several potential antemortem biomarkers in the diagnosis of DLB, measures of the glucose metabolism in the occipital cortex may be an informative diagnostic aid to distinguish DLB from AD; and (2) a pathological process that generates widespread spongiform change and gliosis in long projection fibers may contribute, at least in part, to the characteristic imaging features of DLB. (C) 2000 Academic Press.
引用
收藏
页码:247 / 256
页数:10
相关论文
共 29 条
[1]
Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease [J].
Albin, RL ;
Minoshima, S ;
DAmato, CJ ;
Frey, KA ;
Kuhl, DA ;
Sima, AAF .
NEUROLOGY, 1996, 47 (02) :462-466
[2]
[Anonymous], 1997, Neurobiol Aging, V18, pS1
[3]
DEFINED NEUROFILAMENT, TAU-AMYLOID AND BETA-AMYLOID PRECURSOR PROTEIN EPITOPES DISTINGUISH ALZHEIMER FROM NON-ALZHEIMER SENILE PLAQUES [J].
ARAI, H ;
LEE, VMY ;
OTVOS, L ;
GREENBERG, BD ;
LOWERY, DE ;
SHARMA, SK ;
SCHMIDT, ML ;
TROJANOWSKI, JQ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (06) :2249-2253
[4]
No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia [J].
Arai, H ;
Satoh-Nakagawa, T ;
Higuchi, M ;
Morikawa, Y ;
Miura, M ;
Kawakami, H ;
Seki, H ;
Takase, S ;
Sasaki, H .
NEUROSCIENCE LETTERS, 1998, 256 (03) :174-176
[5]
TAU IN CEREBROSPINAL-FLUID - A POTENTIAL DIAGNOSTIC MARKER IN ALZHEIMERS-DISEASE [J].
ARAI, H ;
TERAJIMA, M ;
MIURA, L ;
HIGUCHI, S ;
MURAMATSU, T ;
MACHIDA, N ;
SEIKI, H ;
TAKASE, S ;
CLARK, CM ;
LEE, VMY ;
TROJANOWSKI, JQ ;
SASAKI, H .
ANNALS OF NEUROLOGY, 1995, 38 (04) :649-652
[6]
Fujiwara T, 1997, Ann Nucl Med, V11, P307
[7]
Clinical and neuropathological findings in Lewy body dementias [J].
Galasko, D ;
Katzman, R ;
Salmon, DP ;
Hansen, L .
BRAIN AND COGNITION, 1996, 31 (02) :166-175
[8]
GREENBERG SG, 1992, J BIOL CHEM, V267, P564
[9]
HANSEN L, 1990, NEUROLOGY, V40, P1
[10]
A NEUROPATHOLOGICAL SUBSET OF ALZHEIMERS-DISEASE WITH CONCOMITANT LEWY BODY DISEASE AND SPONGIFORM CHANGE [J].
HANSEN, LA ;
MASLIAH, E ;
TERRY, RD ;
MIRRA, SS .
ACTA NEUROPATHOLOGICA, 1989, 78 (02) :194-201